Skip to content

Comparison of 3.0T and 1.5T MRCP for the evaluation of pancreatic cysts

Comparison of 3.0T and 1.5T MRCP for the evaluation of pancreatic cysts

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON27590
Enrollment
20
Registered
2015-09-01
Start date
2015-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cysts Pancreascysten

Interventions

Patients who are planned to undergo surveillance with MRI/MRCP will undergo 3.0T MRI/MRCP with contrast (gadovist) instead of 1.5T MRI/MRCP with gadovist. Imaging features of 3.0T MRI/MRCP and previo

Sponsors

Academic Medical Center Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ‐ Patients with one or more pancreatic cysts (≥ 1 cm) ‐ ≥ 18 years old ‐ Previous 1.5T MRI/MRCP within 2 years of inclusion ‐ Written informed consent

Exclusion criteria

Exclusion criteria: &#8208; Clear or likely connection between the cyst and the PD on previous 1.5T MRI/MRCP &#8208; Clear imaging, biochemical and/or cytological features of serous/mucinous cystic neoplasms (i.e. honeycomb-like cyst, central scar, large unilocular cyst or Carcinoembryonic antigen (CEA) < 5). &#8208; Medical history of chronic pancreatitis &#8208; Any contraindication for MRI according to local guidelines

Design outcomes

Primary

MeasureTime frame
Primary endpoint is the number of patients in whom a connection between the pancreatic cyst and PD can be visualized with increased certainty on 3.0T compared with 1.5T MRI/MRCP, evaluated by an experienced radiologist using a 5-point scale: 1: no connection PD 2: unlikely connection PD 3: undetermined connection PD 4: likely connection PD 5: clear connection PD

Secondary

MeasureTime frame
1. Change in follow-up or treatment strategy according to the current guidelines (International Association of Pancreatology (IAP) and European Cystic Tumor Study Group. 2. Visualization of worrisome features with 3.0T compared with 1.5T MRI/MRCP: &#8208; Mural nodules &#8208; Thickened/enhancing cyst walls 3. Difference in cyst morphology on 3.0T compared with 1.5T MRI/MRCP: &#8208; Lobulation &#8208; Pleomorphism 4. Amount of artefacts, evaluated by using a 3-point scale: - 1: artefacts causing difficulties evaluating images - 2: minor/moderate artefacts without diagnostic relevance - 3: (almost) no artefacts 5. Interobserver agreement: intraclass correlation coefficient (ICC) values higher than 0.8 are considered to be excellent concordance, values between 0.6 and 0.8 as good, values between 0.4 and 0.6 as moderate, values between 0.2 and 0.4 as fair and values below 0.2 as poor

Contacts

Public ContactS. Lekkerkerker

Dept. of Gastroenterology and Hepatology Academic Medical Center Meibergdreef 9, C2-310

s.j.lekkerkerker@amc.nl+31-205662061

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)